Osteoporosis Trial, Recruiting NCT05787808 Sponsor: Meddoc Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT05787808
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any gender who are 55 years of age or older and have been diagnosed with osteopenia (a condition where bone density is lower than normal but not low enough to be called osteoporosis, defined by a T-score below 0.0 but higher than -2.5 on a bone density scan)

Who may not be able to join:

  • People who have an eating disorder
  • People who have a known digestive or gastrointestinal condition
  • People whose liver or kidneys are not functioning normally
  • People who have Type 1 diabetes
  • People who have Type 2 diabetes that is not well controlled
  • People who have been diagnosed with cancer
  • People who have taken steroid medications (such as cortisone or prednisone) or other immune-suppressing medications within the last 3 weeks before the trial starts
  • People who are currently receiving treatment to slow bone loss or to build bone (confirm with trial site for specific medication types)
  • People who have taken part in another clinical drug trial within the last 6 weeks before this trial starts
  • People who have a known allergy to milk products
  • People who are not able to understand the information provided about the trial
  • People who are unwilling or unable to provide written consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anne C Whist, PhD, Tine

Phone: +47 41326325

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Meddoc
Registry
ClinicalTrials.gov
Start date
2 May 2023
Est. completion
15 September 2025

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Bone Mineral Density; Bone Mineral Density; Bone Mineral Density; Bone Mineral Density

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov